Julius Wilder, MD
Internal Medicine · Durham, NCNPI 1598924995
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Ipsen Biopharmaceuticals, Inc at 49.1% of the total. 2025 is the largest year on record at $50,566, more than ten times the $140 reported in 2019. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $869.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$48K
- Amgen$21K
- Gilead$14K
- Intercept Pharmaceuticals, Inc.$6K
- Exact Sciences$5K
- Janssen Research & Development, LLC$2K
- plus $1K from 6 others
Across 136 payments — averaging $2832.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$264K
- Gilead$87K
- Novo Nordisk AS$22K
- Eli Lilly$12K
What the payments were for
- Consulting fees$47,49549%
- Speaking & faculty fees$36,87338%
- Travel & lodging$7,2017%
- Food & beverage$5,7656%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 31 | $47,820 |
| Amgen | 28 | $20,808 |
| Gilead | 23 | $14,374 |
| Intercept Pharmaceuticals, Inc. | 7 | $6,437 |
| Exact Sciences | 5 | $4,789 |
| Janssen Research & Development, LLC | 1 | $1,740 |
| Mallinckrodt Hospital Products Inc. | 3 | $362 |
| Mirum Pharmaceuticals, Inc. | 4 | $350 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $273 |
| Madrigal Pharmaceuticals | 2 | $192 |
| Novo Nordisk | 2 | $119 |
| Johnson & Johnson | 1 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$18,310
- IQIRVO$15,271
- Livdelzi$7,271
- OCALIVA$6,245
- Cologuard Collection Kit$4,750
- Otezla$1,740
- TERLIVAZ$249
- RESMETIROM$142
- XIFAXAN$115
- Livmarli$112
How this compares
$97,334 in reported general payments places this provider in the 95th percentile of 3,302 internal medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azathioprine | 24 | $1,190 |
| Tenofovir Disoproxil Fumarate | 19 | $1,031 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 40 | $870 |
| Pantoprazole Sodium | 12 | $240 |
| Omeprazole | 20 | $229 |
| Carvedilol | 11 | $153 |
| Prednisone | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Durham
- Nirmish ShahDurham$862K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Patricia LugarDurham$197K
- Rebecca RichDurham$160K
- Adam DevoreDurham$112K
- Kevin ThomasDurham$101K
- Richard RiedelDurham$95K
- Jennifer RymerDurham$73K
- Jamie ToddDurham$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.